Table 2 Patient characteristics
Total (n = 8) | SHG → AEF (n = 4) | AEF → SHG (n = 4) | |
|---|---|---|---|
Age, median (IQR), years | 80 (76–81) | 80 (78–83) | 78 (74–81) |
Gender, male (number, %) | 7 (87.5%) | 3 (75%) | 4 (100%) |
Height, median (IQR), cm | 167 (153–170) | 167 (149–172) | 166 (153–170) |
Weight, median (IQR), kg | 56 (46–71) | 51 (44–58) | 65 (48–82) |
Body mass index, median (IQR), kg/m2 | 20.5 (15.1–25.6) | 17.1 (14.4–20.9) | 25.2 (19.1–28.5) |
Source of sepsis, n, (%) | |||
Intrathoracic | 2 (25%) | 1 (25%) | 1 (25%) |
Intraabdominal | 4 (50%) | 3 (75%) | 1 (25%) |
Urogenital | 1 (25%) | 0 (0%) | 1 (25%) |
Skin/soft tissue/bone/joint | 1 (25%) | 0 (0%) | 1 (25%) |
APACHE II score, median (IQR) | 21 (16–26) | 23 (14–28) | 19 (16–25) |
SOFA score, median (IQR) | 11 (9–13) | 12 (10–14) | 10 (8–13) |
ICU stay, median (IQR), day | 4.5 (4.0–27.8) | 7 (4.3–30.8) | 4.0 (4.0–26.5) |
Hospital mortality, n, (%) | 5 (62.5%) | 3 (75%) | 2 (50%) |
Acute kidney injury, n, (%) | 3 (37.5%) | 1 (25%) | 2 (50%) |
Lactate, median (IQR), mg/dL | 34.7 (19.0–65.7) | 45.7 (27.3–65.7) | 22.0 (15.0–181.1) |
Procalcitonin, median (IQR), ng/mL | 5.2 (3.8–17.2) | 12.8 (4.8–46.7) | 4.2 (1.5–8.3) |
Glasgow Coma Scale, median (IQR) | 13 (6–15) | 10 (4–15) | 14 (8–15) |
Noradrenaline, median (IQR), μg/kg/min | 0.3 (0.2–0.35) | 0.28 (0.20–0.47) | 0.30 (0.11–0.4) |